Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
Brouwers S, Heimgartner R, Laptseva N, Aguzzi A, Ehl NF, Fehr T, Hitz F, Jung HH, Kälin J, Manz MG, Müllhaupt B, Ruschitzka F, Seeger H, Stussi G, Zweier M, Flammer AJ, Gerber B, Schwotzer R. Brouwers S, et al. Among authors: flammer aj. Swiss Med Wkly. 2024 Feb 15;154:3485. doi: 10.57187/s.3485. Swiss Med Wkly. 2024. PMID: 38579306 Free article.
Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry.
Sokolski M, Trenson S, Reszka K, Urban S, Sokolska JM, Biering-Sørensen T, Højbjerg Lassen MC, Skaarup KG, Basic C, Mandalenakis Z, Ablasser K, Rainer PP, Wallner M, Rossi VA, Lilliu M, Loncar G, Cakmak HA, Ruschitzka F, Flammer AJ. Sokolski M, et al. Among authors: flammer aj. Cardiol J. 2024;31(4):512-521. doi: 10.5603/cj.98489. Epub 2024 Jun 4. Cardiol J. 2024. PMID: 38832553 Free PMC article.
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expression.
Rieger MJ, Pabst T, Jeker B, Paul P, Bergamini F, Bühler MM, Condoluci A, Flammer AJ, Rossi D, Stussi G, Gerber B, Schwotzer R. Rieger MJ, et al. Among authors: flammer aj. Ann Hematol. 2024 Oct;103(10):4163-4170. doi: 10.1007/s00277-024-05901-x. Epub 2024 Jul 17. Ann Hematol. 2024. PMID: 39020041 Free PMC article.
Cardiac amyloidosis.
Laptseva N, Benz DC, Schwotzer R, Flammer AJ. Laptseva N, et al. Among authors: flammer aj. Swiss Med Wkly. 2024 Nov 14;154:4186. doi: 10.57187/s.4186. Swiss Med Wkly. 2024. PMID: 39571050 Free article. Review.
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure Registry.
Guidetti F, Lund LH, Benson L, Hage C, Musella F, Stolfo D, Mol PGM, Flammer AJ, Ruschitzka F, Dahlstrom U, Rosano GMC, Braun OÖ, Savarese G. Guidetti F, et al. Among authors: flammer aj. Eur J Heart Fail. 2023 Dec;25(12):2164-2173. doi: 10.1002/ejhf.3049. Epub 2023 Oct 18. Eur J Heart Fail. 2023. PMID: 37795642 Free article.
Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis.
Perez-Shibayama C, Gil-Cruz C, Cadosch N, Lütge M, Cheng HW, De Martin A, Frischmann K, Joachimbauer A, Onder L, Papadopoulou I, Papadopoulou C, Ring S, Krebs P, Vu VP, Nägele MP, Rossi VA, Parianos D, Zsilavecz VW, Cooper LT, Flammer A, Ruschitzka F, Rainer PP, Schmidt D, Ludewig B. Perez-Shibayama C, et al. Nat Cardiovasc Res. 2024 Mar;3(3):301-316. doi: 10.1038/s44161-024-00432-0. Epub 2024 Feb 19. Nat Cardiovasc Res. 2024. PMID: 39196111 Free PMC article.
150 results